NewslettersCell Therapy NewsA Second-Generation CD38-CAR-T Cell for the Treatment of Multiple MyelomaBy Bob - April 17, 20230143The authors developed a second-generation CAR construct and generated CAR-T cells targeting CD38 molecule.[Cancer Medicine]Full Article